31 Dec '15, 11am

Singapore Developer of Alzheimer's Drug Plans U.S. IPO

KUALA LUMPUR, Malaysia—A Singaporean company focused on developing treatments for Alzheimer’s disease has invited banks to pitch for a mandate to advise it on a potential public offering after results come in from late-stage clinical drug trials, expected in the middle of 2016. The owners of TauRx Pharmaceuticals Ltd., which counts Singapore state investment company Temasek and Southeast Asia’s largest casino operator, Genting, as investors, are looking at listing on the Nasdaq Stock Market as early as 2017 in a deal that...

Full article: http://www.wsj.com/articles/singapore-developer-of-alzhei...

Tweets

Singapore developer of Alzheimer’s drug plans U...

wsj.com 31 Dec '15, 6am

KUALA LUMPUR, Malaysia—A Singaporean company focused on developing treatments for Alzheimer’s disease has invited banks to...

The US government approves drug-producing “GMO” chickens https://t.co/v6lbyeLMvU

The US government approves drug-producing “GMO”...

inhabitat.com 30 Dec '15, 6pm

The US Food and Drug Administration (FDA) has approved a chicken that has been genetically engineered to produce a drug in...

Exercise and the onset of Alzheimer's

Exercise and the onset of Alzheimer's

runnersworld.co.uk 29 Dec '15, 1am

Every morning, Geno Meyers, 67, wakes up and asks his wife, “Do we have a race today?” Early-onset Alzheimer’s disease has...